Kevin Fitzgerald
Chief Tech/Sci/R&D Officer at ALNYLAM PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Currently, Kevin Fitzgerald occupies the position of Chief Scientific Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc. He received an undergraduate degree from Cornell University and a doctorate from Princeton University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/03/2024 | 13,418 ( 0.01% ) | 2 M $ | 31/03/2024 | |
OVID THERAPEUTICS INC.
-.--% | 22/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Kevin Fitzgerald active positions
| Companies | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2016 |
| OVID THERAPEUTICS INC. | Director/Board Member | 06/10/2021 |
Training of Kevin Fitzgerald
| Cornell University | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Kevin Fitzgerald
